Novo Nordisk Discloses Insider Share Transactions
Ticker: NONOF · Form: 6-K · Filed: Nov 13, 2024 · CIK: 353278
Sentiment: neutral
Topics: insider-trading, disclosure, regulation
Related Tickers: NVO
TL;DR
Novo Nordisk execs and board members bought/sold shares, check the 6-K for details.
AI Summary
Novo Nordisk A/S filed a Form 6-K on November 13, 2024, reporting transactions in its shares by board members, executives, and associated persons. This disclosure is in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The filing was made on November 12, 2024, from Bagsvaerd, Denmark.
Why It Matters
This filing provides transparency into the trading activities of company insiders, which can offer insights into their confidence in the company's future performance.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of insider trading activity and does not indicate any new material risks for the company.
Key Players & Entities
- NOVO NORDISK A S (company) — Registrant
- Novo Nordisk (company) — Company name mentioned in the announcement
- Bagsværd, Denmark (location) — Location of the company and announcement
- November 12, 2024 (date) — Date of the company announcement
- November 13, 2024 (date) — Filing date of the 6-K
- Regulation No. 596/2014 (regulation) — Regulation governing market abuse disclosures
- Article 19 (regulation) — Specific article within Regulation No. 596/2014
FAQ
What type of transactions are being disclosed by Novo Nordisk?
The filing discloses transactions in Novo Nordisk shares made by the company's board members, executives, and their associated persons.
What regulation governs these disclosures?
These disclosures are made in accordance with Article 19 of Regulation No. 596/2014 on market abuse.
When was the company announcement made?
The company announcement was made on November 12, 2024.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on November 13, 2024.
Where is Novo Nordisk headquartered?
Novo Nordisk is headquartered in Bagsvaerd, Denmark.
Filing Stats: 667 words · 3 min read · ~2 pages · Grade level 14.8 · Accepted 2024-11-13 06:00:08
Filing Documents
- f6k_111224.htm (6-K) — 35KB
- logo.jpg (GRAPHIC) — 76KB
- ca.jpg (GRAPHIC) — 24KB
- 0001171843-24-006304.txt ( ) — 174KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf of the undersigned, thereunto duly authorized. Date: November 12, 2024 NOVO NORDISK A/S Lars Fruergaard Jørgensen Chief Executive Officer